Keyphrases
Next-generation Sequencing
88%
Acute Myeloid Leukemia
41%
Myelodysplastic Syndrome
34%
Next-generation Sequencing Data
30%
Tumor
29%
Merkel Cell Carcinoma
27%
Metagenomic Next-generation Sequencing (mNGS)
26%
Merkel Cell Polyomavirus (MCPyV)
25%
Whole Genome Sequencing
21%
Fluorescence in Situ Hybridization
20%
Formalin-fixed Paraffin-embedded Tissue
19%
Whole Exome Sequencing
18%
Single nucleotide Variant
16%
Tumor Protein p53 (TP53)
14%
Gene mutation
14%
Immunohistochemistry
13%
In Cancer
13%
Insertion-deletion
13%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
13%
High-grade Neuroendocrine Carcinoma
12%
Clinical Laboratory
12%
Somatic mutation
12%
RNA Sequencing (RNA-seq)
10%
Chronic Lymphocytic Leukemia
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Sequence Data
10%
Acute Leukemia
10%
T Cells
10%
Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
10%
Myeloid Neoplasms
10%
Copy number Variation
10%
Sequence Variants
9%
DNA Sequencing
9%
Glioblastoma
9%
Leukemia
9%
Formalin-fixed
9%
B Cells
8%
Neuroendocrine Carcinoma
8%
Myeloid Malignancies
8%
Somatic Variants
8%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
8%
RNA-based
8%
Hybrid Capture
7%
High Sensitivity
7%
In Silico
7%
Mutant Allele Frequency
7%
College of American Pathologists
7%
Hematopoietic Stem Cells
7%
Subclone
7%
International Consensus Classification
7%
Medicine and Dentistry
Next Generation Sequencing
59%
Neoplasm
48%
Acute Myeloid Leukemia
30%
Myelodysplastic Syndrome
26%
Merkel Cell Carcinoma
26%
Merkel Cell Polyomavirus
22%
Diseases
19%
Exome Sequencing
17%
Gene Mutation
16%
Neuroendocrine Carcinoma
16%
Fluorescence in Situ Hybridization
15%
Immunohistochemistry
13%
Head and Neck Squamous Cell Carcinoma
13%
Malignant Neoplasm
12%
Biological Marker
11%
Single Nucleotide Polymorphism
11%
Acute Leukemia
10%
Hematopoietic Cell
10%
Glioblastoma
10%
Breast Implant
9%
In Silico
9%
B-Cell Chronic Lymphocytic Leukemia
9%
RNA Sequence
9%
Pathologist
9%
Gene Fusion
9%
T Cell
8%
Morphology
8%
Overall Survival
8%
Somatic Mutation
8%
Cancer
8%
Somatics
7%
Neck
7%
Allele
7%
Non Small Cell Lung Cancer
7%
Clinical Oncology
7%
Epstein Barr Virus
7%
Anaplastic Large Cell Lymphoma
6%
Malignant Transformation
6%
Metastatic Carcinoma
6%
Minimal Residual Disease
6%
Molecular Pathology
6%
Classical Hodgkin Lymphoma
6%
Ganglioglioma
6%
Myeloproliferative Neoplasm
6%
Retinoblastoma
6%
microRNA
6%
Whole Genome Sequencing
6%
Exome
6%
Virus
6%
B Cell
6%
Biochemistry, Genetics and Molecular Biology
Next Generation Sequencing
100%
Myeloid
38%
Genomics
29%
Gene Mutation
22%
Whole Genome Sequencing
21%
Single-Nucleotide Polymorphism
21%
Exome Sequencing
17%
Fluorescence in Situ Hybridization
13%
Allele
13%
Indel
12%
Exome
12%
B Cell
11%
Hematopoietic Cell
11%
Germ Cell
10%
Germline
10%
Genetics
9%
Deep Sequencing
9%
RNA Sequence
9%
RNA
8%
Genome Sequencing
8%
Overall Survival
8%
Clonal Variation
8%
Clonality
8%
Epidermal Growth Factor Receptor
7%
Cytogenetics
7%
Somatic Mutation
7%
Malignant Transformation
6%
MicroRNA
6%
Hematopoiesis
6%
P53
6%
DNA Sequence
5%
Molecular Disease
5%
Gene Fusion
5%
Mouse Model
5%
Exon
5%
Capillary Electrophoresis
5%
DNMT3A
5%
Chromosomal Rearrangement
5%
T Cell
5%
Carcinogenesis
5%
Interphase
5%
